Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma
about
Molecular pathogenesis of secondary acute promyelocytic leukemiaPilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group studyAt the frontier of progress for paediatric oncology: the neuroblastoma paradigm.Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation.Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse.Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experience.Surveillance imaging and radiation exposure in the detection of relapsed neuroblastoma.Late mortality after hematopoietic SCT for a childhood malignancy.Late Effects and Survivorship Issues in Patients with Neuroblastoma
P2860
Q35560260-1548633A-3CEA-418F-A2B0-C959E604E4B5Q35565630-983FB970-1FAA-4E7B-AA6C-2E1DD8D8428AQ38161274-55D8DF8E-BBA8-4E6B-A97C-200A80DCCDDAQ39052883-9383421C-0990-44FA-9086-F030B12CE831Q39560187-1272C5B4-E334-4FF9-9136-2989C27700A2Q40122866-FE6F5207-59DC-455C-BA40-E30346274AB9Q44517995-F15A205F-43CD-4D38-9060-B7D6416C5740Q47559681-F5D580E4-791D-46E6-8B49-33D97ED5770AQ50357815-0511920D-EFB3-49FE-8696-C1A1753AD84FQ52982329-37C32BCE-02CE-464E-A589-4248800ABCD9Q53107532-78F3AE03-0FBA-4CD3-97D0-B400BDD58ED0Q58798636-C91F3E00-5A20-4CF5-9B1B-8DF39FA66C52
P2860
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Reduced risk of secondary leuk ...... in patients with neuroblastoma
@ast
Reduced risk of secondary leuk ...... in patients with neuroblastoma
@en
type
label
Reduced risk of secondary leuk ...... in patients with neuroblastoma
@ast
Reduced risk of secondary leuk ...... in patients with neuroblastoma
@en
prefLabel
Reduced risk of secondary leuk ...... in patients with neuroblastoma
@ast
Reduced risk of secondary leuk ...... in patients with neuroblastoma
@en
P2093
P2860
P356
P1476
Reduced risk of secondary leuk ...... in patients with neuroblastoma
@en
P2093
Brian H Kushner
Kim Kramer
Li-Xuan Qin
Nai-Kong V Cheung
Suresh C Jhanwar
P2860
P356
10.1002/PBC.21931
P577
2009-07-01T00:00:00Z